Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities. This segment also provides risk solutions for casualty and property, as well as for agricultural, livestock, and bloodstock businesses; aviation and space business; and marine and offshore energy business. The Life & Health Reinsurance segment offers credit life, enhanced annuities, group life and health, 60+, and Sharia-compliant Takaful reinsurance products. This segment also provides risk solutions in the areas of critical illness, disability, health, longevity, long term care, and mortality. In addition, it offers various financial solutions, including new-business financing; monetization of embedded value; reserve and solvency relief; and divestiture of non-core businesses. The company was formerly known as Hannover Rückversicherung AG and changed its name to Hannover Rück SE in March 2013. The company was founded in 1966 and is headquartered in Hanover, Germany. Hannover Rück SE is a subsidiary of Talanx AG.
Industry, Sector and Symbol
Industry Insurance - Reinsurance
Sub-IndustryN/A
SectorFinancial Services
CIKN/A
Phone+49-511-56040
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees3,317
Next Earnings DateN/A
OptionableNot Optionable
Hannover Re (FRA:HNR1) Frequently Asked Questions
What is Hannover Re's stock symbol?
Hannover Re trades on the FRA under the ticker symbol "HNR1."
What price target have analysts set for HNR1?
20 brokers have issued 1 year price objectives for Hannover Re's stock. Their forecasts range from €104.00 to €130.00. On average, they anticipate Hannover Re's stock price to reach €115.67 in the next twelve months. This suggests that the stock has a possible downside of 13.4%. View Analyst Price Targets for Hannover Re.
What is the consensus analysts' recommendation for Hannover Re?
20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hannover Re in the last year. There are currently 4 sell ratings and 16 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Hannover Re.
Has Hannover Re been receiving favorable news coverage?
Media headlines about HNR1 stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Hannover Re earned a news sentiment score of 1.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
Who are some of Hannover Re's key competitors?
Some companies that are related to Hannover Re include 1st SUFFIELD Fi/SH (FSFF), 1ST TR ENERGY I/SH (FIF), 3i Group (TGOPF), 8IP Emerging Companies (8EC), Aberdeen Asian Income Fund (AAIF), Aberdeen Australia Equity Fund (IAF), Aberdeen Emerging Markets Invstmt (AEMC), Aberdeen Latin American Income Fund (ALAI), Aberdeen New Dawn Investment Trust (ABD), Aberdeen Smaller Coms High Incm Trst (ASCI), Aberforth Smaller Companies Trust (ASL), Aberforth Split Level Income Trust (ASIT), Aberforth Split Level Income Trust PLC Preferred Shares (ASIZ), ABN AMRO Group (ABMRF) and Absa Group (AGRPY).
What other stocks do shareholders of Hannover Re own?
Who are Hannover Re's key executives?
Hannover Re's management team includes the folowing people:
- Mr. Ulrich Wallin, Chairman of the Exec. Board & CEO (Age 65)
- Mr. Roland Helmut Vogel, CFO & Member of the Exec. Board (Age 60)
- Dr. Michael Pickel, Member of the Exec. Board (Age 59)
- Dr. Klaus Wilhelm Miller, Member of the Exec. Board (Age 59)
- Mr. Claude Jacques Chèvre, Member of the Exec. Board (Age 52)
What is Hannover Re's stock price today?
One share of HNR1 stock can currently be purchased for approximately €133.60.
What is Hannover Re's official website?
How can I contact Hannover Re?
Hannover Re's mailing address is Karl-Wiechert-Allee 50, HANNOVER, 30625, Germany. The company can be reached via phone at +49-511-56040.
MarketBeat Community Rating for Hannover Re (FRA HNR1)
MarketBeat's community ratings are surveys of what our community members think about Hannover Re and other stocks. Vote "Outperform" if you believe HNR1 will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HNR1 will underperform the S&P 500 over the long term. You may vote once every thirty days.
